IN148482B
(fr)
|
1977-06-03 |
1981-03-07 |
Pfizer |
|
US4370328A
(en)
|
1977-11-03 |
1983-01-25 |
Pfizer Inc. |
Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
|
CA1114379A
(fr)
*
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phtalazines
|
US5001125A
(en)
*
|
1984-03-26 |
1991-03-19 |
Janssen Pharmaceutica N.V. |
Anti-virally active pyridazinamines
|
ATE49205T1
(de)
*
|
1984-09-14 |
1990-01-15 |
Asta Pharma Ag |
Substituierte benzylphthalazinon-derivate.
|
US4868179A
(en)
*
|
1987-04-22 |
1989-09-19 |
Cohn Jay N |
Method of reducing mortality associated with congestive heart failure using hydralazine and isosorbide dinitrate
|
US5106973A
(en)
*
|
1987-11-23 |
1992-04-21 |
Janssen Pharmaceutica N.V. |
Pyridzainamine derivatives
|
US4963676A
(en)
*
|
1988-02-09 |
1990-10-16 |
Georgia State University Foundation, Inc. |
Di-substituted phthalazines
|
JO1645B1
(en)
*
|
1989-12-26 |
1991-11-27 |
شركة جانسين فارماسوتيكا ان. في |
Pyridazine compounds are antibacterial viruses
|
EP0449203B1
(fr)
*
|
1990-03-30 |
1994-12-07 |
Mitsubishi Chemical Corporation |
Dérivés de 4-phénylphthalazine
|
US5100893A
(en)
*
|
1990-04-18 |
1992-03-31 |
Janssen Pharmaceutica N.V. |
Antipicornaviral pyridazinamines
|
TW279162B
(fr)
*
|
1991-09-26 |
1996-06-21 |
Mitsubishi Chem Corp |
|
CH683965A5
(it)
*
|
1993-02-19 |
1994-06-30 |
Limad Marketing Exp & Imp |
Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
|
US5716956A
(en)
*
|
1995-06-07 |
1998-02-10 |
Bearsden Bearsden Bio, Inc. |
Dihydrophthalazine antagonists of excitatory amino acid receptors
|
ATE236134T1
(de)
*
|
1996-12-18 |
2003-04-15 |
Neurogen Corp |
Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
|
CO4950519A1
(es)
*
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
ES2265929T3
(es)
|
1999-03-30 |
2007-03-01 |
Novartis Ag |
Derivados de ftalazina para el tratamiento de enfermedades inflamatorias.
|
AR025068A1
(es)
*
|
1999-08-10 |
2002-11-06 |
Bayer Corp |
Pirazinas sustituidas y piridazinas fusionadas, composicion farmaceutica que las comprenden, uso de dichos compuestos para la manufactura de un medicamentocon actividad inhibidora de angiogenesis
|
US6689883B1
(en)
|
1999-09-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
DOP2000000070A
(es)
*
|
1999-09-28 |
2002-02-28 |
Bayer Healthcare Llc |
Piridinas y piridacinas sustituidas con actividad de inhibición de angiogénesis
|
DE19963607B4
(de)
*
|
1999-12-23 |
2005-12-15 |
Schering Ag |
Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
|
US7977333B2
(en)
*
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
AR028782A1
(es)
*
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
US6903101B1
(en)
|
2000-08-10 |
2005-06-07 |
Bayer Pharmaceuticals Corporation |
Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
|
GB0111078D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Novartis Ag |
Organic compounds
|
US20030236259A1
(en)
*
|
2002-02-05 |
2003-12-25 |
Rolf Hohlweg |
Novel aryl- and heteroarylpiperazines
|
GB0223341D0
(en)
*
|
2002-10-08 |
2002-11-13 |
Groningen Acad Ziekenhuis |
Organic compounds
|
GB0310726D0
(en)
|
2003-05-09 |
2003-06-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
NZ546990A
(en)
*
|
2003-11-20 |
2010-03-26 |
Janssen Pharmaceutica Nv |
7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
SG150533A1
(en)
|
2003-11-20 |
2009-03-30 |
Janssen Pharmaceutica Nv |
6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
UA89618C2
(ru)
*
|
2003-12-05 |
2010-02-25 |
Янссен Фармацевтика Н.В. |
6-замещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли(адф-рибоза)полимеразы
|
AU2005260102A1
(en)
|
2004-05-08 |
2006-01-12 |
Novartis International Pharmaceutical Ltd. |
3-aryl-5,6-disubstituted pyridazines
|
WO2005120092A1
(fr)
*
|
2004-06-02 |
2005-12-15 |
Ktfreetel Co., Ltd. |
Systeme de prestation de service applicatif et gestionnaire et modifiant l'interface utilisateur et procede associe
|
AU2005259189B2
(en)
*
|
2004-06-30 |
2011-04-21 |
Janssen Pharmaceutica N.V. |
Phthalazine derivatives as PARP inhibitors
|
MXPA06014541A
(es)
|
2004-06-30 |
2007-03-23 |
Janssen Pharmaceutica Nv |
Derivados de quinazolindiona como inhibidores de la poli(adp-ribosa) polimerasa.
|
CA2568835C
(fr)
|
2004-06-30 |
2014-05-27 |
Janssen Pharmaceutica N.V. |
Derives de quinazolinone en tant qu'inhibiteurs de parp
|
JP2008506716A
(ja)
*
|
2004-07-16 |
2008-03-06 |
ニトロメッド インコーポレーティッド |
心不全に関連する組成物および方法
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
MX2007006233A
(es)
|
2004-11-24 |
2007-11-23 |
Medpointe Healthcare Inc |
Composiciones que comprenden azelastina y metodos de uso de la misma.
|
US8758816B2
(en)
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
CN103110635A
(zh)
|
2005-07-04 |
2013-05-22 |
海波因特制药有限责任公司 |
组胺h3受体拮抗剂
|
EP1981868A2
(fr)
*
|
2006-01-27 |
2008-10-22 |
Pfizer Products Inc. |
Composes derives d aminophthalazine
|
WO2007097951A2
(fr)
*
|
2006-02-17 |
2007-08-30 |
Nitromed, Inc. |
Procédés utilisant des composés d'hydralazine et du dinitrate d'isosorbide ou du mononitrate d'isosorbide
|
WO2007136626A1
(fr)
*
|
2006-05-16 |
2007-11-29 |
Nitromed, Inc. |
Formulations en doses solides de composés d'hydralazine
|
EA016026B1
(ru)
*
|
2006-05-29 |
2012-01-30 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
3-(1,3-бензодиоксол-5-ил)-6-(4-циклопропилпиперазин-1-ил)пиридазин, его соли и сольваты и его применение в качестве антагониста н3 рецептора гистамина
|
CA2678248C
(fr)
|
2007-03-08 |
2016-06-28 |
Janssen Pharmaceutica Nv |
Derives de quinolinone comme inhibiteurs de parp et de tank
|
DK2137162T3
(en)
*
|
2007-03-15 |
2018-11-26 |
Novartis Ag |
Organic compounds and their applications
|
EP2014656A3
(fr)
*
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
Nouveaux antagonistes d'hétéocycliques h3
|
US8404713B2
(en)
*
|
2007-10-26 |
2013-03-26 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as PARP inhibitors
|
SI2271626T1
(sl)
|
2008-03-27 |
2015-03-31 |
Janssen Pharmaceutica, N.V. |
Tetrahidrofenantridinoni in tetrahidrociklopentakinolinoni, kot inhibitorji polimerizacije PARP in tubulina
|
US8168644B2
(en)
*
|
2008-03-27 |
2012-05-01 |
Janssen Pharmaceutica Nv |
Quinazolinone derivatives as tubulin polymerization inhibitors
|
NZ588001A
(en)
*
|
2008-04-29 |
2012-06-29 |
Lilly Co Eli |
Disubstituted phthalazine hedgehog pathway antagonists
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
PT2364185E
(pt)
*
|
2008-11-03 |
2013-07-24 |
Lilly Co Eli |
Ftalazina dissubstituída antagonista da via hedgehog
|
WO2010056620A1
(fr)
*
|
2008-11-17 |
2010-05-20 |
Eli Lilly And Company |
Pyridazines tétrasubstituées antagonistes de la voie hedgehog
|
EP2358698B1
(fr)
|
2008-11-17 |
2012-09-05 |
Eli Lilly and Company |
Pyridazine tétrasubstituée en tant qu' antagoniste de la voie de signalisation hedgehog
|
WO2016123796A1
(fr)
*
|
2015-02-06 |
2016-08-11 |
Abbvie Inc. |
Phtalazines substituées
|
WO2018080216A1
(fr)
*
|
2016-10-28 |
2018-05-03 |
Daewoong Pharmaceutical Co., Ltd. |
Dérivé de phénylphtalazine, sa méthode de préparation et composition pharmaceutique le comprenant
|
US11618751B1
(en)
|
2022-03-25 |
2023-04-04 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
|
WO2022165173A1
(fr)
*
|
2021-01-28 |
2022-08-04 |
The Scripps Research Institute |
Composés et leur utilisation pour le traitement de troubles neurodégénératifs, dégénératifs et métaboliques
|
WO2022253326A1
(fr)
*
|
2021-06-05 |
2022-12-08 |
药捷安康(南京)科技股份有限公司 |
Inhibiteur de l'inflammasome nlrp3 et son utilisation
|
CA3233482A1
(fr)
*
|
2021-09-30 |
2023-04-06 |
Origiant Pharmaceutical Co., Ltd |
Utilisation pharmaceutique et procede de preparation d'un derive d'heteroaryl-phtalazine substitue
|